Beatrice Sanchez and Mariana Arias drive around their city, Winston-Salem, N.C., in search of a very specific population of residents: Latinos with prediabetes. The two women, both bilingual and Hispanic, are recruiting participants for a Type 2 diabetes prevention study called "La Comunidad," a lower-cost local version of the landmark Diabetes Prevention Program trial that staved off diabetes through changes in diet and physical activity

Researchers use modified messenger RNA to produce a vaccine that protected mice and nonhuman primates from infection.

Researchers tap into ongoing dengue studies to improve antibody-based diagnostic tests for Zika and address unanswered questions about the emerging virus’s epidemiology.

Scientists studying Zika are moving quickly to generate a vaccine against the mosquito-borne virus that continues to spread through South and Central America

Researchers examine the blood of people infected with dengue virus, finding a few Zika-neutralizing antibodies among mostly enhancing ones.

The “just right” binding properties of a monoclonal antibody from an Ebolavirus survivor help it neutralize the virus.

Scientists link an immune phenotype present at birth to the development of food allergies a year later.

Researchers design antibody-like proteins to awaken and destroy HIV holdouts.

Much of the CD4+ T-cell death that occurs during HIV infection may be caused by direct delivery of the virus from neighboring cells, a study shows.

When gynecologic oncologist Paola Gehrig makes a treatment plan, she has little to go by to make sure her patient gets the best chemotherapy dose with the least amount of toxicity.